Proud Sponsor of the Organization of Women in International Trade - Badge

Antitrust Lawyer Blog

Commission clears acquisition of Fisher by Thermo, subject to conditions
Doyle, Barlow & Mazard PLLC

On November 9, the European Commission approved the proposed acquisition of Fisher Scientific International Inc. by Thermo Electron Corporation. Both companies are based in the United States and supply products and services for laboratory activities. The Commission’s clearance is conditional upon the divestiture of Genevac, Fisher’s subsidiary active in the production and sale of centrifugal…

Continue reading ›
Commission approves planned acquisition of Intermagnetics by Philips
Doyle, Barlow & Mazard PLLC

The European Commission cleared the proposed acquisition by the Dutch company Philips of the US-based company Intermagnetics on November 7. After examining the operation, the Commission concluded that the transaction would not significantly impede effective competition in the European Economic Area or any substantial part of it. Philips markets a wide range of electrical and…

Continue reading ›
Commissioner Kroes welcomes withdrawal of obstacles to Abertis-Autostrade merger and offer of full cooperation
Doyle, Barlow & Mazard PLLC

Following her meeting in Brussels on November 7 with Antonio Di Pietro, Italy’s Minister for Public Works, European Commissioner for Competition Neelie Kroes expressed her satisfaction that the Italian authorities removed what the Commission considered to be unjustified obstacles to a merger between Abertis of Spain and Autostrade of Italy. Commissioner Kroes also welcomed Mr…

Continue reading ›
Marketer Settles With FTC for Sending Unwanted E-Mails
Doyle, Barlow & Mazard PLLC

A company that sent unsolicited commercial e-mail after consumers asked it to stop agreed to pay a $50,717 civil penalty on November 6 to settle Federal Trade Commission charges that it violated federal law. The FTC charged Yesmail Inc., doing business as @Once Corporation, with sending e-mail on behalf of its clients more than 10…

Continue reading ›
Zango, Inc. Settles FTC Charges
Doyle, Barlow & Mazard PLLC

On November 3, Zango, Inc., formerly known as 180solutions, Inc., one of the world’s largest distributors of adware, and two principals agreed to settle Federal Trade Commission charges that they used unfair and deceptive methods to download adware and obstruct consumers from removing it, in violation of federal law. The settlement bars future downloads of…

Continue reading ›
FTC Challenges Terms of Watson Pharmaceuticals’ Acquisition of Andrx
Doyle, Barlow & Mazard PLLC

On October 31, the Federal Trade Commission announced its decision to challenge the terms of Watson Pharmaceuticals, Inc.’s proposed $1.9 billion acquisition of Andrx Corporation, a deal that would have led to competitive problems in the markets for 13 generic drug products. In allowing the deal to proceed while addressing these competitive problems, the Commission…

Continue reading ›
Commission clears planned acquisition of Bayer Diagnostics by Siemens
Doyle, Barlow & Mazard PLLC

On October 31st, the European Commission cleared the proposed acquisition of Bayer Diagnostics, the diagnostic division of Bayer Healthcare, a business unit of Bayer AG of Germany, by Siemens AG of Germany. The Commission concluded that the transaction would not significantly impede effective competition in the European Economic Area or any substantial part of it.…

Continue reading ›
Justice Department Will Not Oppose Proposal By Standard-Setting Organization on Disclosure and Licensing of Patents
Doyle, Barlow & Mazard PLLC

On October 30, the DOJ announced that it will not oppose a proposal by the VMEbus International Trade Association (“VITA”) to implement a policy on the disclosure and licensing of patents. The policy requires the disclosure of essential patents, commitments to license essential patent claims on fair, reasonable, and non-discriminatory terms, and declarations of the…

Continue reading ›
Aerial view of Washington DC cityscape from Arlington Virginia USA.

Contact Us

Fill out the form or call us at (202) 589-1834 to schedule your consultation.